MAKSIM MAMONKIN to Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
This is a "connection" page, showing publications MAKSIM MAMONKIN has written about Precursor T-Cell Lymphoblastic Leukemia-Lymphoma.
Connection Strength
4.231
-
SOHO State of the Art Updates and Next Questions | CAR T Cells in T Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma. Clin Lymphoma Myeloma Leuk. 2025 Feb; 25(2):77-88.
Score: 0.831
-
Feasibility and preclinical efficacy of CD7-unedited CD7 CAR T?cells for T?cell malignancies. Mol Ther. 2023 01 04; 31(1):24-34.
Score: 0.737
-
CD7 CAR: sword and shield. Blood. 2022 07 28; 140(4):293-294.
Score: 0.731
-
Detonating T-ALL. Blood. 2020 09 10; 136(11):1218-1219.
Score: 0.642
-
CD7-edited T cells expressing a CD7-specific CAR for the therapy of T-cell malignancies. Blood. 2017 07 20; 130(3):285-296.
Score: 0.511
-
A T-cell-directed chimeric antigen receptor for the selective treatment of T-cell malignancies. Blood. 2015 Aug 20; 126(8):983-92.
Score: 0.446
-
Engineering naturally occurring CD7- T cells for the immunotherapy of hematological malignancies. Blood. 2022 12 22; 140(25):2684-2696.
Score: 0.188
-
Adoptive Cell Therapy for Acute Myeloid Leukemia and T-Cell Acute Lymphoblastic Leukemia. Cancer J. 2019 May/Jun; 25(3):199-207.
Score: 0.146